3-D Matrix, Ltd. (TYO:7777)
210.00
+50.00 (31.25%)
Jun 13, 2025, 3:30 PM JST
3-D Matrix Revenue
3-D Matrix had revenue of 1.79B JPY in the quarter ending January 31, 2025, with 55.49% growth. This brings the company's revenue in the last twelve months to 6.66B, up 78.16% year-over-year. In the fiscal year ending April 30, 2024, 3-D Matrix had annual revenue of 4.59B with 98.27% growth.
Revenue (ttm)
6.66B
Revenue Growth
+78.16%
P/S Ratio
2.65
Revenue / Employee
62.86M
Employees
106
Market Cap
17.65B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Apr 30, 2024 | 4.59B | 2.27B | 98.27% |
Apr 30, 2023 | 2.31B | 808.00M | 53.65% |
Apr 30, 2022 | 1.51B | 482.00M | 47.07% |
Apr 30, 2021 | 1.02B | 352.00M | 52.38% |
Apr 30, 2020 | 672.00M | 344.00M | 104.88% |
Apr 30, 2019 | Pro | Pro | Pro |
Apr 30, 2018 | Pro | Pro | Pro |
Apr 30, 2017 | Pro | Pro | Pro |
Apr 30, 2016 | Pro | Pro | Pro |
Apr 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,222.12B |
Takeda Pharmaceutical Company | 4,581.55B |
Daiichi Sankyo Company | 1,886.26B |
HOYA Corporation | 869.37B |
Terumo | 1,036.17B |
Otsuka Holdings | 2,393.18B |
Astellas Pharma | 1,912.32B |
Olympus | 997.33B |